Recruiting
Phase 2

Testosterone Replacement in Male Cancer Survivors With Fatigue and Low Testosterone

Sponsor:

Seattle Institute for Biomedical and Clinical Research

Code:

NCT04049331

Conditions

Hypogonadism, Male

Fatigue Syndrome, Chronic

Eligibility Criteria

Sex: Male

Age: 18 - 54

Healthy Volunteers: Not accepted

Interventions

Testosterone Undecanoate 750 MG/3 ML Intramuscular Solution [AVEED]

placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information